...
首页> 外文期刊>International Journal of Experimental Diabetes Research: Experimental Diabesity Research >Exploring the Mechanism of Skeletal Muscle in a Tacrolimus-Induced Posttransplantation Diabetes Mellitus Model on Gene Expression Profiles
【24h】

Exploring the Mechanism of Skeletal Muscle in a Tacrolimus-Induced Posttransplantation Diabetes Mellitus Model on Gene Expression Profiles

机译:在基因表达谱上探讨躯干诱导的后翻膜糖尿病MELLITUS模型中骨骼肌机制

获取原文

摘要

Objective. Posttransplantation diabetes mellitus (PTDM) is a known complication of transplantation that affects the prognosis. Tacrolimus (Tac or FK506) is a widely used immunosuppressant that has been reported to be a risk factor for PTDM and to further induce complications in heart and skeletal muscles, but the mechanism is still largely unknown. In our preliminary experiments, we found that after Tac treatment, blood glucose increased, and the weight of skeletal muscle declined. Here, we hypothesize that tacrolimus can induce PTDM and influence the atrophy of skeletal muscle. Methods. We designed preliminary experiments to establish a tacrolimus-induced PTDM model. Gene expression profiles in quadriceps muscle from this rat model were characterized by oligonucleotide microarrays. Then, differences in gene expression profiles in muscle from PTDM rats that received tacrolimus and control subjects were analyzed by using GeneSpring GX 11.0 software (Agilent). Functional annotation and enrichment analysis of differentially expressed genes (DEGs) helped us identify clues for the side effects of tacrolimus. Results. Our experiments found that the quadriceps in tacrolimus-induced PTDM group were smaller than those in the control group. The study identified 275 DEGs that may be responsible for insulin resistance and the progression of PTDM, including 86 upregulated genes and 199 downregulated genes. GO and KEGG functional analysis of the DEGs showed a significant correlation between PTDM and muscle development. PPI network analysis screened eight hub genes and found that they were related to troponin and tropomyosin. Conclusions. This study explored the molecular mechanism of muscle atrophy in a tacrolimus-induced PTDM model by bioinformatics analyses. We identified 275 DEGs and identified significant biomarkers for predicting the development and progression of tacrolimus-induced PTDM.
机译:客观的。产后形成糖尿病(PTDM)是一种已知的移植复杂性,其影响预后。 Tacrolimus(TAC或FK506)是一种广泛使用的免疫抑制剂,据报道是PTDM的危险因素,并进一步诱导心脏和骨骼肌的并发症,但该机制仍然很大程度上是未知的。在我们的初步实验中,我们发现在TAC治疗后,血糖增加,骨骼肌的重量下降。在这里,我们假设Tacrolimus可以诱导PTDM并影响骨骼肌的萎缩。方法。我们设计了初步实验,以建立一个标准士诱导的PTDM模型。通过寡核苷酸微阵列表征来自该大鼠模型的Quadriceps肌肉中的基因表达谱。然后,通过使用Genespring Gx 11.0软件(Agilent)分析来自接受巨杆菌和对照受试者的PTDM大鼠的肌肉中基因表达谱的差异。差异表达基因(DEGS)的功能注释和富集分析帮助我们识别Tacrolimus副作用的线索。结果。我们的实验发现,Tacrolimus诱导的PTDM组中的Quadriceps小于对照组中的Quadriceps。该研究确定了275只可能对胰岛素抵抗和PTDM的进展负责,包括86个上调基因和199个下调基因。 GO和Kegg功能分析参数显示PTDM和肌肉发育之间的显着相关性。 PPI网络分析筛选了八个枢纽基因,发现它们与肌钙蛋白和对卓染素有关。结论。该研究通过生物信息学分析探讨了肌肉诱导的PTDM模型中肌肉萎缩的分子机制。我们确定了275次,并确定了重大的生物标志物,以预测他克莫司诱导的PTDM的发展和进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号